肠道疾病检测市场报告：2030 年趋势、预测与竞争分析

肠道疾病检测的趋势与预测

预计到 2030 年，全球肠道疾病检测市场将达到约 51 亿美元，2024 年至 2030 年复合年增长率为 3.5%。该市场的主要驱动力是肠道疾病检测设备的不断创新和技术进步，对样本利用率的日益关注，以及更快、更有效率、更便宜的计算硬体的兴起以及更好的网路连接。全球肠道疾病检测市场的未来看起来充满希望，水和食品市场也充满机会。

Lucintel 预测，由于食品食品肠道疾病发病率的增加，传统检测在预测期内仍将是最大的部分。

由于肠道疾病发病率不断增加，以及为提高对该地区肠道疾病可用性的认识而加大的监管力度，北美似乎将在预测期内继续成为最大的细分市场。

肠道疾病检测市场新趋势

技术进步、不断变化的医疗保健需求以及对食品安全的日益关注推动了肠道疾病检测市场的新兴趋势。这些趋势正在塑造市场动态并影响新测试方法和途径的发展。

• 分子诊断的整合：分子诊断在病原体检测中提供高灵敏度和特异性，从而实现更快、更准确的结果。这一趋势正在透过缩短交付时间和提高检测能力来提高肠道疾病检测的效率。随着这些技术变得更加便宜，它们的采用预计会增加，并在临床和现场环境中得到更广泛的应用。
• 开发快速检测解决方案快速检测可提供快速结果以实现及时诊断，这对于快速治疗至关重要。这一趋势正在缩小快速回应紧急情况和偏远地区测试请求的差距。易于获得的快速检测的存在可以帮助改善疾病管理，并透过在疫情爆发期间即时做出反应来减轻卫生系统的负担。
• 利用人工智慧和机器学习：利用人工智慧和机器学习进行巨量资料分析，透过识别传统手段无法看到的模式来提高诊断准确性。在预测事件发生并设计个人化治疗方法的同时，治疗过程变得更有效率。人工智慧的使用有望提供更准确、更可行的见解，从而彻底改变疾病监测和管理。
• 专注于食品安全和预防：即将检测解决方案整合到食品生产和分销过程中，以防止污染。对食品安全的关注可以在肠道病原体到达消费者之前及早识别和遏制它们。因此，预防性方法催生了新的检测技术，减少了患有食源性疾病的人数并改善了公共卫生。
• 扩大新兴市场的检测基础设施：扩大新兴市场的检测基础设施将解决获得医疗保健的不平等并支持疾病监测。对诊断工具和检测设施的投资有助于高负担地区检测、管理和控制肠道疾病。这样的方向不仅可以提高全球卫生公平性，还可以更好地管理弱势社区的疫情。

分子诊断、快速检测、人工智慧融入食品安全通讯协定以及基础设施进步等新兴趋势正在改变肠道疾病检测市场。他们正在推动检测技术的进步，提高全球医疗保健服务系统各级的检测准确性，并完善针对疾病爆发的全球应对策略。

肠道疾病检测市场近期趋势

肠道疾病检测市场的最新趋势是由技术进步、对食品安全的日益关注以及不断变化的医疗保健需求所推动的。这些发展的结果是提高诊断准确性、提高检测速度和整体疾病管理。

• 先进的分子诊断工具简介：这些工具在检测肠道病原体方面表现出高灵敏度和特异性，缩短了诊断时间。它还可以更轻鬆地追踪疫情并制定个人化的治疗计划。采用此类技术将透过提高效率和可靠性来改善临床实践和公共卫生部门。
• 快速检测平台的发展：快速检测平台的即时对于快速诊断和治疗所需的结论性结果至关重要。这些进步将加强对疫情的快速反应和病例的有效管理。快速检测的可用性改善了检测的机会，特别是在偏远和服务不足的地区。
• 扩大新兴市场的检测能力：扩大新兴市场的检测能力：扩大新兴市场的检测能力可解决疾病监测和获得医疗保健方面的差距。这项进展正在改善疾病负担高的地区肠道疾病的检测和管理。它还透过减少疫情的发生来支持全球卫生努力。
• 数位医疗技术的整合：数位医疗技术将提高诊断准确性，同时也有利于疾病爆发的即时监测。人工智慧和资料分析使决策变得更加容易，从而可以提供疫情爆发的早期预警征兆。这种整合简化了诊断过程并提高了疾病管理的整体有效性。
• 重视食品安全措施：改善食品安全措施有助于防止污染并降低食源性疾病的风险。这些措施在食品生产和分销中实施，以确保产品安全。这项进展透过减少与食品相关的肠道疾病而改善了公共卫生。

肠道疾病检测市场的最新开拓包括提高诊断能力、加强检测基础设施以及整合先进技术。这些将加强疾病控制、疫情应对并改善整体公共卫生。

肠道疾病检测市场的策略性成长机会

技术进步和对公共卫生的日益关注正在为肠道疾病检测市场的各个应用领域创造策略性成长机会。识别这些成长机会使公司能够解决成长和创新的关键领域。

• 扩大就地检验：照护现场有助于快速诊断并实现治疗。因此，公司可以开发和销售易于在临床环境和现场使用的检测套组。更重要的是，扩大即时检测可以改善获得诊断服务的机会，特别是在资源有限的偏远地区。
• 多重检测的开发：多重检测的使用可以在一次测试中同时检测多种肠道病原体，从而提高效率并减少诊断感染所需的时间。这项技术进步创建了一个全面监测疾病爆发的系统，同时也有助于识别合併感染。对于从事多重检测的公司来说，有一个庞大的市场，因为它们提供了比竞争产品更通用、更有效率的测试方法。
• 人工智慧和机器学习的结合：人工智慧和机器学习的结合可以透过分析大型资料集和疫情预测来提高诊断准确性。因此，这种整合将实现更复杂和及时的检测，透过提供可能影响人类和动物的疾病的早期预警来提高检测的整体有效性。投资这些技术的公司也可以成为与各类感染疾病相关的监测和管理应用现代化的领导者。
• 专注于食品安全检测：更好的食品安全检测可以防止污染并降低食物中毒的风险。开发改进的食源性病原体分离解决方案将增加公共卫生效益，并有助于解决公众日益增长的担忧。这为市场相关人员提供了一个绝佳的投资机会，以确保人们不会对所吃的任何东西上瘾。
• 拓展新兴市场：新兴市场因其不断增长的医疗需求和发达的基础设施而成为市场开拓的理想地点。透过扩展到这些地区，公司可以进入开拓的市场，并为更好的疾病管理和监测做出贡献。此举将建立全球健康倡议并扩大市场范围。

肠道疾病检测市场的策略性成长机会包括扩大就地检验、开拓多重检测、整合人工智慧、专注于食品安全以及进入新兴市场。这些机会为创新和市场扩张提供了途径，以满足关键的医疗保健需求并加强疾病管理。

肠道疾病检测市场的驱动因素与挑战

肠道疾病检测市场受到许多市场驱动因素和挑战的影响，例如技术进步、经济状况和监管条件。分析这些因素有助于相关人员了解动态市场并做出明智的决策。

推动肠道疾病检测市场的因素包括：

1.技术进步：技术进步：技术进步提高了肠道疾病检测的准确性、速度和效率。 PCR、NGS 和多重检测等技术创新提高了检测能力并缩短了交付时间。由于需求的增加，这些进步将有助于及时、准确的诊断市场的扩大。

2.食品安全问题日益严重：食品安全问题日益严重，推动了对先进检测解决方案的需求。因此，食品安全法规变得更加严格，并且需要用于测试目的的新技术。为了应对这一趋势，公司正在投资检测受污染食品并降低疫情爆发风险的产品线。

3.肠道疾病盛行率不断上升：肠道疾病盛行率不断上升，增加了对有效诊断测试的需求。这项驱动因素将刺激新型诊断平台的出现并扩大测试基础设施，从而刺激市场成长。随着负担的增加，需要创造性的检测机制，医疗保健投资也会增加。

4.增加对医疗基础设施的投资：对医疗基础设施的投资，特别是在新兴市场，将改善疾病监测并建立检测能力。这将透过增加诊断工具的获取和改善整体疾病管理来推动市场成长。加强基础设施将能够引入先进的检测技术系统，从而改善健康结果。

肠道疾病检测市场面临的挑战包括：

1. 监管和合规问题：对于製造商来说，诊断测试的开发和核准可能很复杂，因为监管挑战会增加成本。他们必须满足监管要求并应对标准的变化。实现市场准入和确保产品品质既需要合规性，但也构成了严重的障碍。

2. 供应链中断：供应链中断可能导致製造延迟和诊断测试成本更高。企业需要製定策略来管理供应链风险并保持原材料的稳定供应。如果您需要维持生产计划并满足市场需求，解决供应链限制至关重要。

3. 先进技术高成本：分子诊断和多重检测等先进技术的成本可能难以大规模使用。高价格可能会限制测试解决方案的采用，尤其是在资源匮乏的地区。为了应对这项挑战，公司必须寻找降低创新价格的方法，同时提高其可用性。

技术进步、食品安全问题日益严重、疾病盛行率上升、医疗基础设施投资、政府政策等是影响肠道疾病检测产业的主要驱动和阻碍因素因素。监管问题、高成本和供应链中断等挑战也正在影响市场。了解这些因素将有助于相关人员驾驭市场并发现成长和创新的机会。

肠道疾病检测的细分

该研究包括按技术、最终用途和地区对全球肠道疾病检测的预测。

国家肠道疾病检测市场展望

由于人们对食源性疾病的认识不断提高、技术进步以及公共卫生优先事项的变化，肠道疾病检测市场近年来取得了重大进展。改进的诊断方法、提高的测试准确性和快速的结果变得越来越重要。这是需要更好地管理疾病和应对疫情爆发的结果。这些变化的速度将根据每个主要市场（例如美国、中国、德国、印度和日本）的医疗基础设施、疾病流行和法规环境而有所不同。

• 中国 由于对诊断技术和基础设施的巨额投资，中国肠道疾病检测市场正在快速成长。这需要开发能够处理大量测试的高通量自动化系统，这与日益增加的食品安全问题和不断增加的人口密度有关。此外，中国政府正在资助研究和开发，以提高食品安全标准并应对疫情。此外，将人工智慧和机器学习纳入诊断过程可以提高肠道疾病检测的效率和准确性。
• 德国：德国透过改善分子诊断和法规结构，在肠道疾病检测方面做出了巨大努力。该国致力于提高测试准确性，同时透过同时检测多种病原体的多重检测等创新来缩短诊断时间。此外，德国正在透过将先进的资料分析和数位平台整合到测试程序中来发展公共卫生应对能力。这些发展符合德国对食品安全管理和疾病预防高标准的承诺。
• 印度：印度肠道疾病诊断的最新趋势是采用更便宜、更容易取得的诊断工具，例如快速抗原检测和方便的分子测定。透过努力加强农村和服务不足人口的检测基础设施，疾病监测和控制正在改善。与世界各地的组织和政府的伙伴关係重点是改善资料收集和扩大测试能力。这些进展是对因卫生条件差和食品安全问题导致肠道疾病病例数量不断增加的回应。
• 日本：技术进步和对预防保健的日益重视正在推动日本肠道疾病检测市场的成长。在日本，PCR和生物感测器等先进诊断技术的使用正在取得进展，以便更准确地检测引起肠道感染疾病的病原微生物。日本正投入资金进行研究，开发新的测试方法，同时增强现有的测试方法。我们也正在努力整合国家卫生监测系统和检测解决方案，以不仅加强疫情检测，而且提高应对能力。

常问问题

Q.1 肠道疾病检测的市场规模有多大？

A1. 到 2030 年，全球肠道疾病检测市场预计将达到 51 亿美元。

Q.2 肠道疾病检测市场的成长预测如何？

A2. 2024年至2030年，全球肠道疾病检测市场预计将以3.5%的复合年增长率成长。

Q.3 影响肠道疾病检测市场成长的关键驱动因素有哪些？

A3. 该市场的主要驱动力是肠道疾病检测设备的创新和技术进步，对样本利用率的日益关注，更快、更熟练和更便宜的计算技术以及更好的网路连接。

Q4.市场的主要细分市场是：

A4. 全球肠道疾病检测市场前景广阔，水和食品市场充满机会。

Q5.市场的主要企业是：

A5. 主要肠道疾病检测公司如下：

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于对食品的需求增加以及肠道疾病发病率的增加，传统检测在预测期内仍将是最大的部分。

Q7. 未来五年预计哪些地区的市场成长最快？

A7. 由于肠道疾病发生率不断上升，以及为提高人们对肠道疾病的认识而加大的监管力度，北美地区将在预测期内继续增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章 全球肠道疾病检测市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球肠道疾病检测市场趋势（2018-2023）与预测（2024-2030）
• 按技术分類的全球肠道疾病检测市场
  • 传统的
  • 迅速地
  • 强调便利性
  • 聚合酵素链锁反应
  • 免疫检测
  • 层析法和光谱
• 全球肠道疾病检测市场（依最终用途）
  • 食品
  • 水

第四章 2018-2030年区域市场趋势及预测分析

• 全球肠道疾病检测市场按地区划分
• 北美肠道疾病检测市场
• 欧洲肠道疾病检测市场
• 亚太肠道疾病检测市场
• 其他区域性肠道疾病检测市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球肠道疾病检测市场的技术成长机会
  • 全球肠道疾病检测市场最终用途的成长机会
  • 全球肠道疾病检测市场按地区成长机会
• 全球肠道疾病检测市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球肠道疾病检测市场的能力
  • 全球肠道疾病检测市场的併购与合资
  • 认证和许可

第七章主要企业概况

• Merck
• Thermo Fisher Scientific
  • SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Enteric Disease Testing Trends and Forecast

The future of the global enteric disease testing market looks promising with opportunities in the water and food markets. The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancement for quicker, proficient, and cheaper computing hardware tied with better network connectivity.

Lucintel forecasts that traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as, increasing incidences of enteric diseases.

North America will remain the largest segment over the forecast period due to the rising incidences of enteric diseases and increasing regulatory efforts for spreading awareness regarding the availability of enteric diseases in this region.

Emerging Trends in the Enteric Disease Testing Market

Emerging trends in the enteric disease testing market are driven by advancements in technology, changing healthcare needs, and increased focus on food safety. These trends are shaping the market dynamics and influencing the development of new testing methodologies and approaches.

• Integration of Molecular Diagnostics: Molecular diagnostics offer high sensitivity and specificity for detecting pathogens, enabling quicker and more accurate results. This trend is improving the efficiency of enteric disease testing by reducing turnaround times and enhancing detection capabilities. As these technologies become more affordable, their adoption is expected to increase, leading to more widespread use in both clinical and field settings.
• Development of Rapid Testing Solutions: Rapid: tests give quick results for timely diagnoses that are important in prompt treatment. This tendency is filling the gap of swiftly responding to testing requirements under emergency conditions as well as at a distance. The presence of easily accessible rapid tests helps improve disease control and lighten health systems' load through instant response during outbreaks.
• Use of Artificial Intelligence and Machine Learning: Big data analysis by AI and machine learning enhances diagnostic precision by recognizing patterns which would otherwise not be seen using traditional means. Testing processes are made more efficient while predicting outbreaks and designing personalized treatment approaches. More accurate and actionable insights are expected to be provided through the use AI, thus revolutionizing disease surveillance and management.
• Emphasis on Food Safety and Prevention: This is about integrating testing solutions into food production and distribution processes for the purpose of preventing contamination. An increased focus on food safety aids in early identification and containment of enteric pathogens before they reach consumers. As a result, preventive approaches have given rise to new testing technologies and reduced the rate at which people suffer from foodborne diseases thereby improving public health.
• Expansion of Testing Infrastructure in Emerging Markets: Expanding the testing infrastructure in emerging countries addresses gaps in access to healthcare and aids disease surveillance. The investments made towards diagnostic tools and testing facilities are helping detect, manage, and control enteric diseases in areas with high disease burden. This direction is enhancing global health fairness as well as enabling better outbreak management among underprivileged communities.

These emerging trends molecular diagnostics, rapid tests, AI incorporated into food safety protocols, advancing infrastructures are transforming the market for enteric disease tests. They are propelling technological advancements in detection techniques, improving test accuracy rates at all levels of healthcare delivery systems globally as well as refining worldwide response strategies against ailment outbreaks.

Recent Developments in the Enteric Disease Testing Market

Recent developments in the enteric disease testing market have been driven by technological advancements, increased focus on food safety and changing healthcare needs. Improved diagnostic accuracy, testing speed, and overall disease management are a result of these developments.

• Introduction of Advanced Molecular Diagnostic Tools: These tools show high degree of sensitivity and specificity to detect enteric pathogens hence reducing time taken to diagnose them. They allow better tracking of outbreaks as well as personalized treatments plans. Through such technologies adoption, efficiency and reliability will be boosted thus improving both clinical settings and also public health sectors.
• Growth of Rapid Testing Platforms: The immediacy of rapid testing platforms is vital in getting conclusive results, which are necessary for immediate diagnosis and treatment. Such an advancement enhances quick response to outbreaks and effective management of cases. Rapid tests availability has improved access to testing particularly in remote and underserved areas.
• Expansion of Testing Capabilities in Emerging Markets: Expansion of Testing Capabilities in Emerging Markets addresses gaps in disease surveillance and healthcare access. This development is improving the detection and management of enteric diseases in regions with high disease burden. It also supports global health efforts by reducing the incidence of outbreaks.
• Integration of Digital Health Technologies: Diagnostic accuracy can be enhanced through digital health technologies while at the same time facilitating real-time monitoring on disease outbreaks. AI and data analytics have facilitated decision making thereby predicting early outbreak signs. With this integration, the diagnostic process has been made simpler thereby enhancing overall effectiveness for managing diseases
• Increased Emphasis on Food Safety Measures: Improved food safety measures help prevent contamination and reduce the risk of foodborne illnesses. These are implemented in food production and distribution to ensure safe products. This advancement has resulted in better public health outcomes through reducing enteric diseases associated with food.

Latest developments around enteric disease testing market include; improving diagnostic capabilities, enhanced testing infrastructure, and integration of advanced technologies. They enhance disease control, reaction to outbreaks as well as enhance overall public wellness.

Strategic Growth Opportunities for Enteric Disease Testing Market

Advancements in technology and growing emphasis on public health have created strategic growth opportunities within different application domains in the enteric disease testing market. Identifying these opportunities allows companies to address key areas for growth and innovation.

• Expansion of Point-of-Care Testing: Tests at the point of care, can help in quick diagnostics and make treatment possible. As a result, companies can develop and sell testing kits that are easy to use in both clinical and field settings. More importantly, expanding point-of- care testing may improve access to diagnostic services especially in remote areas with limited resources.
• Development of Multiplex Assays: The use of multiplex assays enables the simultaneous detection of many enteric pathogens in one test which increases efficiency and decreases the time required to diagnose infection. This technological advancement provides for an all-inclusive monitoring system for disease prevalence while helping to identify co-infections. There is a very big market for companies that deal with multiplex assays because they offer a more versatile as well as efficient way of doing tests than their competitor products.
• Integration of AI and Machine Learning: AI together with machine learning can enhance accuracy in diagnoses through analyzing large data sets as well as predicting outbreaks. Consequently, this integration allows better refined as well as timely detections thereby improving overall effectiveness of examinations by giving early warning signs on diseases that may affect humans or animals alike. Such firms investing on these technologies can be leaders regarding modernization even when it comes to surveillance and management applications related to different types infectious diseases.
• Focus on Food Safety Testing: Better food safety testing prevents contamination and decreases the danger of food poisoning. The development of improved solutions for foodborne pathogen isolation can help increase public health benefits and address the increasing concerns of the masses. This provides an incredible chance for market players to invest in ensuring that people are not poisoning themselves with whatever they eat.
• Expansion into Emerging Markets: A number of medical needs that are growing as well as infrastructure being developed that makes emerging markets good places for expansion. By going into these regions, companies can reach out to untapped markets where they contribute towards better disease management and surveillance. Such a move establishes global health initiatives and extends market coverage.

Strategic growth opportunities in the enteric disease testing market include expanding point-of-care testing, developing multiplex assays, integrating AI, focusing on food safety, and entering emerging markets. These opportunities offer avenues for innovation and market expansion, addressing critical healthcare needs and enhancing disease management.

Enteric Disease Testing Market Driver and Challenges

The enteric disorder examination market is influenced by a number of drivers and challenges, such as technological advancement, economic situation, and regulatory conditions. Analyzing these factors helps stakeholders to understand the dynamic market and make informed decisions.

The factors responsible for driving the enteric disease testing market include:

1. Technological Advancements: Technological improvements increase the accuracy, speed and efficiency of enteric disease testing. Innovations like PCR, NGS and multiplex assays improve detection abilities and shorten turnaround times. These advances help expand the market for accurate diagnostics that are timely due to increased demand.

2. Growing Food Safety Concerns: The increasing concerns pertaining to food safety are driving the demand for advanced testing solutions. This driver prompts new technologies for testing purposes while tightening regulations on food safety. In response to this trend, businesses invest in product lines that detect contaminated foods thus mitigating any danger of outbreaks.

3. Rising Prevalence of Enteric Diseases: A rise in the prevalence of enteric diseases increases the demand for effective diagnostic tests. This driver stimulates market growth by encouraging emergence of novel diagnostic platforms and expands testing infrastructure. As the burden grows, there is need for creative testing mechanisms and increased investment in health care.

4. Increased Healthcare Infrastructure Investment: Investments in healthcare infrastructure particularly in emerging markets, improve disease surveillance and test capacity building. This driver increases access to diagnostics tools and improves general management of diseases thereby supporting market growth. Enhanced infrastructure allows for the installation of sophisticated testing technology systems leading to better health outcomes.

Challenges in the enteric disease testing market are:

1. Regulatory and Compliance Issues: The development and approval of diagnostic tests could be complicated for manufacturers by the regulatory challenges that raise costs. Regulatory requirements must be met and changes in standards adapted to. Achieving market entry and ensuring product quality both require compliance, but it also acts as a serious barrier.

2. Supply Chain Disruptions: Manufacturing delays and higher costs of diagnostic testing can result from supply chain disruptions. Companies need to come up with strategies to manage supply chain risks and maintain steady supplies of materials. Dealing with supply chain constraints is crucial when production timetables need to be maintained and market demands are supposed to be fulfilled.

3. High Costs of Advanced Technologies: The expense incurred in advanced technologies such as molecular diagnostics, multiplex assays may make them unaffordable at large scale use. High price tags may limit the reach of testing solutions especially in poorly endowed locations with resources. In order to deal with this challenge, companies must look for ways to decrease the price tag on their innovations as well as increase their availability.

Technological advances, increased worries about food safety, increased disease prevalence, investment in health infrastructure and government policies are the key drivers and constraints impacting the enteric disease testing industry. Also affecting the market are challenges like regulatory concerns, high costs, supply chain disruption. Understanding these factors helps stakeholders navigate the market and identify opportunities for growth and innovation.

List of Enteric Disease Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enteric disease testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enteric disease testing companies profiled in this report include-

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• Perkinelmer
• Becton Dickinson

Enteric Disease Testing by Segment

The study includes a forecast for the global enteric disease testing by technology, end use, and region.

Enteric Disease Testing Market by Technology [Analysis by Value from 2018 to 2030]:

• Traditional
• Rapid
• Convenience-Based
• Polymerase Chain Reaction
• Immunoassay
• Chromatography & Spectrometry

Enteric Disease Testing Market by End Use [Analysis by Value from 2018 to 2030]:

• Food
• Water

Enteric Disease Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Enteric Disease Testing Market

The enteric disease testing market has recently witnessed significant advancements due to the increased awareness of foodborne diseases, technological advancements, and change in public health priorities. Improved diagnostics, better testing accuracy and quicker results have become more important. This is as a result of a need to manage diseases better and respond to outbreaks. The rate at which these changes occur differ depending on the healthcare infrastructure existing in the respective key markets such as United States, China, Germany, India and Japan along with their regulatory environment besides disease prevalence.

• China: The enteric disease testing market in China is growing fast with huge investments made in diagnostic technology and infrastructure. This necessitates the development of high throughput automated systems that can handle large numbers of tests and are related to higher food safety concerns and increased population density. In addition, the Chinese government is involved in funding research and development to improve food safety standards as well as respond to outbreaks. Furthermore, incorporation of AI and machine learning into diagnostic processes has led to better efficiency and accuracy during enteric disease testing.
• Germany: Germany has made substantial efforts in enteric disease testing through molecular diagnostics and improved regulatory frameworks. The country is focusing on enhancing test accuracy while reducing time to diagnosis through innovations like multiplex assays for simultaneous multiple pathogen detection. In addition, Germany is developing capacities for public health response by integrating advanced data analytics as well as digital platforms into its testing procedures. These developments are consistent with Germany's commitment to high standards in food safety control and prevention of diseases
• India: Recent developments in diagnosing enteric diseases in India have incorporated more affordable and accessible diagnostic tools such as rapid antigen tests and simplified molecular assays. Disease surveillance and management is being improved through attempts to enhance testing infrastructure in rural areas and underserved populations. Global organizations' partnerships with the government are centered on improving data collection and expanding testing capabilities. These advancements are a response to an increase in cases of enteric diseases as a result of poor sanitation, food safety issues among others.
• Japan: Technological advancements and an increasing emphasis on preventive healthcare are driving the growth of Japan's market for enteric disease testing. The nation is increasingly using PCR and biosensors among other advanced diagnostic techniques for better detection of pathogenic organisms that cause enteric infections. To develop new methodologies for examination while enhancing the already existing ones Japan spends money on research. There is also ongoing effort aimed at integrating the national health surveillance systems with the test solutions so that there can be outbreak detection enhancement as well as response capacities improvement too.

Features of the Global Enteric Disease Testing Market

Market Size Estimates: Enteric disease testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enteric disease testing market size by technology, end use, and region in terms of value ($B).

Regional Analysis: Enteric disease testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use, and regions for the enteric disease testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enteric disease testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the enteric disease testing market size?

Answer: The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2030.

Q.2 What is the growth forecast for enteric disease testing market?

Answer: The global enteric disease testing market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the enteric disease testing market?

Answer: The major drivers for this market are rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancement for quicker, proficient, and cheaper computing hardware tied with better network connectivity.

Q4. What are the major segments for enteric disease testing market?

Answer: The future of the global enteric disease testing market looks promising with opportunities in the water and food markets.

Q5. Who are the key enteric disease testing market companies?

Answer: Some of the key enteric disease testing companies are as follows:

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Q6. Which enteric disease testing market segment will be the largest in future?

Answer: Lucintel forecasts that traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as, increasing incidences of enteric diseases.

Q7. In enteric disease testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the rising incidences of enteric diseases and increasing regulatory efforts for spreading awareness regarding the availability of enteric diseases in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enteric disease testing market by technology (traditional, rapid, convenience-based, polymerase chain reaction, immunoassay, and chromatography & spectrometry), end use (food and water), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Enteric Disease Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Enteric Disease Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Enteric Disease Testing Market by Technology
  • 3.3.1: Traditional
  • 3.3.2: Rapid
  • 3.3.3: Convenience-Based
  • 3.3.4: Polymerase Chain Reaction
  • 3.3.5: Immunoassay
  • 3.3.6: Chromatography & Spectrometry
• 3.4: Global Enteric Disease Testing Market by End Use
  • 3.4.1: Food
  • 3.4.2: Water

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Enteric Disease Testing Market by Region
• 4.2: North American Enteric Disease Testing Market
  • 4.2.1: North American Enteric Disease Testing Market by Technology :Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.2.2: North American Enteric Disease Testing Market by End Use: Food and Water
• 4.3: European Enteric Disease Testing Market
  • 4.3.1: European Enteric Disease Testing Market by Technology :Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.3.2: European Enteric Disease Testing Market by End Use: Food and Water
• 4.4: APAC Enteric Disease Testing Market
  • 4.4.1: APAC Enteric Disease Testing Market by Technology : Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.4.2: APAC Enteric Disease Testing Market by End Use: Food and Water
• 4.5: ROW Enteric Disease Testing Market
  • 4.5.1: ROW Enteric Disease Testing Market by Technology : Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.5.2: ROW Enteric Disease Testing Market by End Use: Food and Water

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Enteric Disease Testing Market by Technology
  • 6.1.2: Growth Opportunities for the Global Enteric Disease Testing Market by End Use
  • 6.1.3: Growth Opportunities for the Global Enteric Disease Testing Market by Region
• 6.2: Emerging Trends in the Global Enteric Disease Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Enteric Disease Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enteric Disease Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Thermo Fisher Scientific
  • 7.1.1: SGS
• 7.4: Eurofins Scientific
• 7.5: Bureau Veritas
• 7.6: Intertek
• 7.7: Romer Labs
• 7.8: PerkinElmer
• 7.9: Becton Dickinson